In a group of end-stage renal disease patients with diabetes, Burbea et al. [22] found a survival advantage in Hp 1-1 patients above 60 years, whereas patients below 60 years demonstrated a better survival when having Hp 2-2. This evidence concerns the gene HP and chronic kidney disease.